Intravenous Nitroglycerin for Retained Placenta Extraction: a Multicenter Study
Status:
Completed
Trial end date:
2010-12-01
Target enrollment:
Participant gender:
Summary
Primary objective The primary objective of this study is to see whether intravenous (IV) NTG
100-200 microgram can effectively help extract retained placenta as compared to placebo, in a
randomized controlled multicenter study.
Secondary objective is to compare the hypotensive effects of NTG as compared to placebo,
including others side effects such as headache, blood loss, or others.